habener glp-1 Interview with Joel Habener, 17th

Research published by institutions including the University of Iowa, National Cancer Institute, and numerous peer-reviewed journals demonstrates several potential benefits: Improved quality of life: Studies consistently show that cancer patients receiving high-dose IV vitamin C alongside conventional treatment report better quality of life, improved performance status, and reduced treatment-related side effects

Recent research suggest its potential in neuroprotection, possibly aiding in conditions like Alzheimers

Campo in the early 1930s

Moreover, the necessity for cold chain storage and restricted shelf life exacerbate logistical challenges, imposing limitations in resource-constrained environments and affecting market feasibility [347]